Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats

Molecular and Cellular Biochemistry

Volumn 308, Issue 1-2, 2008, Pages 101-109

  Marsillach, Judit ^a   Ferré, Natàlia ^b   Camps, Jordi ^a   Rull, Anna ^a   Beltran, Raul ^a   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

B cell leukemia lymphoma 2; Cirrhosis; Fibrosis; Inhibitors of apoptosis; Survivin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BACULOVIRAL IAP REPEAT CONTAINING PROTEIN 2; CARBON TETRACHLORIDE; CASPASE 3; CASPASE 9; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CASPASE ACTIVATED DEOXYRIBONUCLEASE ALPHA; CASPASE ACTIVATED DEOXYRIBONUCLEASE BETA; CD36 ANTIGEN; FAS LIGAND; GELATINASE B; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 4; MATRILYSIN; NEUTROPHIL COLLAGENASE; PROCOLLAGEN; PROCOLLAGEN TYPE 1 ALPHA 2; PROCOLLAGEN TYPE 4 ALPHA 4; PROTEIN BAD; PROTEIN BCL 2; PROTEIN P53; STROMELYSIN; SURVIVIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FIBROGENESIS; GENE EXPRESSION; HISTOPATHOLOGY; LIVER FIBROSIS; LIVER FUNCTION; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT;

ANIMALS; APOPTOSIS; BODY WEIGHT; CARBON TETRACHLORIDE; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MICROTUBULE-ASSOCIATED PROTEINS; ORGAN SIZE; PHENOTYPE; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; REGRESSION ANALYSIS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 38649117875     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9617-0     Document Type: Article

References (39)

1. Schuppan D, Ruehl M, Somasundaram S (2001) Matrix as a modulator of hepatic fibrogenesis. Sem Liv Dis 21:351-372
2. Takehara T, Tatsumi T, Suzuki T, Rucker EB 3rd, Hennighausen L, Jinushi M, Miyagi T, Kanazawa Y, Hayashi N (2004) Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 127:1189-1197
3. Purohit V, Brenner DA (2005) Mechanisms of alcohol-induced hepatic fibrosis: A summary of the Ron Thurman symposium. Hepatology 43:872-878
4. Zhang LJ, Zheng WD, Shi MN, Wang XZ (2006) Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic liver. World J Gastroenterol 12:1918-1923
5. Devereaux QL, Reed JC (1999) IAP family proteins-suppressors of apoptosis. Genes Dev 104:239-252
6. Altieri DC (2006) The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 18:609-615
7. Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L (2005) Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J Med Virol 77:374-381
8. Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL (2006) A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 131:1758-1767
9. Benyon RC, Arthur MJP (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Sem Liv Dis 21:373-384
10. Jiang Y, Liu J, Waalkes M, Kang YJ (2004) Changes in the gene expression associated with carbon tetrachloride-induced liver fibrosis persist after cessation of dosing in mice. Toxicol Sci 79:404-410
11. Lau DT, Luxon BA, Xiao SY, Beard MR, Lemon SM (2005) Intrahepatic gene expression profiles and alpha-smooth actin patterns in hepatitis C virus induced fibrosis. Hepatology 42:273-281
12. Goulter B, Harmer DW, Clark KL (2006) Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue. BMC Genomics 7:34-43
13. Gassó M, Rubio M, Varela G, Cabré M, Caballeria J, Alonso E, Deulofeu R, Camps J, Gimenez A, Pajares M, Pares A, Mato JM, Rodes J (1996) Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J Hepatol 25:200-205
14. Sancho-Bru P, Bataller R, Gasull X, Colmenero J, Khurdayan V, Gual A, Nicolas JM, Arroyo V, Gines P (2005) Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. J Hepatol 43:272-282
15. Goldshmidt O, Yeikilis R, Mawasi N, Paizi M, Gan N, Ilan N, Pappo O, Vlodavsky I, Spira G (2004) Heparanase expression during normal liver development and following partial hepatectomy. J Pathol 203:594-602
16. Arthur MJP (2000) Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279:G245-G249
17. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102:538-549
18. Benyon RC, Iredale JP (2000) Is liver fibrosis reversible? Gut 46:443-446
19. McCrudden R, Iredale JP (2000) Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. Histol Histopathol 15:1159-1168
20. Roderfeld M, Weiskirchen R, Wagner S, Berres ML, Henkel C, Grotzinger J, Gressner AM, Matern S, Roeb E (2006) Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice. FASEB J 20:444-454
21. Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G (2000) Expression on matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 113:443-453
22. Tasci I, Mas MR, Vural SA, Comert B, Alcigir G, Serdar M, Mas N, Isik AT, Ates Y (2006) Rat liver fibrosis regresses better with pegylated interferon α2b and ursodeoxycholic acid treatments than spontaneous recovery. Liver Int 26:261-268
23. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells - a possible new growth factor in serum. FEBS Lett 298:29-32
24. Stetlerstevenson WG, Bersch N, Golde DW (1992) Tissue inhibitor of metalloproteinases-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett 296:231-234
25. Nemeth JA, Rafe A, Steiner M, Goolsby CL (1996) TIMP-2 growth-stimulatory activity: A concentration- and cell type-specific response in the presence of insulin. Exp Cell Res 224:110-115
26. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: Implications for reversibility of liver fibrosis. J Biol Chem 277:11069-11076
27. Neuman MG (2001) Apoptosis in diseases of the liver. Crit Rev Clin Lab Sci 38:109-166
28. Piekarska A, Piekarski J, Szymczak W, Kubiak R (2006) Expression of Ki-67, transforming growth factor β1, and B-cell lymphoma-leukemia-2 in liver tissue of patients with chronic liver diseases. J Gastroenterol Hepatol 21:700-710
29. Novo E, Marra F, Zamara E, Valfre di Bonzo L, Monitillo L, Cannito S, Petrai I, Mazzocca A, Bonacchi A, De Franco RS, Colombatto S, Autelli R, Pinzani M, Parola M (2006) Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 55:1174-1182
30. Ferré N, Marsillach J, Camps J, Mackness B, Mackness M, Riu F, Coll B, Tous M, Joven J (2006) Paraoxonase-1 is associated with oxidative stress, fibrosis and Fas expression in chronic liver diseases. J Hepatol 45:51-59
31. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921
32. Guo M, Hay BA (1999) Cell proliferation and apoptosis. Curr Opin Cell Biol 11:745-752
33. Olie RA, Simoes-Wust AP (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60:2805-2809
34. Sohn J, Khaoustov VI, Xie Q, Chung CC, Krishnan B, Yoffe B (2003) The effect of ursodeoxycholic acid on the survivin in thapsigargin-induced apoptosis. Cancer Lett 191:83-92
35. Song Z, Yao X, Wu M (2003) Direct interaction between survivin and Smac is essential for the anti-apoptotic activity of survivin during Taxol-induced apoptosis. J Biol Chem 278:23130-23140
36. Takashima H, Nakajima T, Moriguchi M, Sekoguchi S, Nishikawa T, Watanabe T, Katagishi T, Kimura H, Minami M, Itoh Y, Kagawa K, Okanoue T (2005) In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma. Liver Int 25:77-84
37. Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EKL (2007) Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol 46:107-114
38. Zwerts F, Lupu F, De Vriese A, Pollefeyt S, Moons L, Altura R, Jinag Y, Maxwell PH, Hill P, Oh H, Rieker C, Collen D, Conway SJ, Conway EM (2007) Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. Blood. DOI 10.1182/ blood-2006-06-028068
39. Caldas H, Fangusaro JR, Boué DR, Holloway MP, Altura RA (2007) Dissecting the role of endothelial SURVIVIN ΔEx3 in angiogenesis. Blood 109:1479-1489